Skip to main content
Clinical Trials/NCT02506569
NCT02506569
Completed
Not Applicable

ProMRI 3T ENHANCED Master Study

Biotronik SE & Co. KG12 sites in 5 countries129 target enrollmentJanuary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Safety of MR (Magnetic Resonance)-Conditional ICDs
Sponsor
Biotronik SE & Co. KG
Enrollment
129
Locations
12
Primary Endpoint
Decrease in sensing amplitude ratios between 1-month post-MRI and pre-MRI
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The investigation is designed to provide supporting evidence for the clinical safety of the Biotronik's new Implantable Cardioverter Defibrillator systems when used under specific 3 Tesla MR conditions .

Registry
clinicaltrials.gov
Start Date
January 2015
End Date
January 15, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Implanted with Implantable Cardioverter Defibrillator (ICD) system according to Clinical Investigational Plan (CIP)
  • ICD system was implanted in the pectoral region
  • Implantation at least 5 weeks prior to enrollment date
  • Patient body height ≥ 140 cm
  • Age ≥ 18 years
  • Right Ventricular pacing threshold (at 0.4 ms) measurable and ≤ 2.0 V
  • Written informed consent
  • Able and willing to complete MRI testing
  • Able and willing to complete all testing required by the clinical protocol
  • Available for all follow-up visits at the investigational site

Exclusion Criteria

  • Standard contraindication for MRI scans
  • Patient shows signs of a twiddler's syndrome, i.e. fiddles with implant
  • Explantation, exchange or reposition of ICD or lead within 5 weeks prior to enrollment date
  • Charging status of the battery is Elective Replacement Indicator (ERI) or End of Service (EOS)
  • MRI scan within 5 weeks prior to enrollment date
  • R-wave sensing amplitude \< 6.5 millivolt
  • Lead impedance less than 200 or greater than 1500 Ohm
  • Life expectancy of less than six months
  • Cardiac surgery in the next six months
  • Pregnant or breastfeeding

Outcomes

Primary Outcomes

Decrease in sensing amplitude ratios between 1-month post-MRI and pre-MRI

Time Frame: 1 Month

Evaluate the percentage of ICD leads with a decrease in the sensing amplitude ratio measured between the Pre-MRI and 1-month post-MRI

Increase in pacing thresholds ratios measured between 1-month post-MRI and pre-MRI

Time Frame: 1 Month

Evaluate the percentage of ICD leads with an increase in the pacing threshold ratio measured between the Pre-MRI and 1-month post-MRI

Serious Adverse Device Effect (SADE)-free rate of implantable cardioverter defibrillators and leads possibly or securely related to the MRI procedure

Time Frame: 1 Month

Study Sites (12)

Loading locations...

Similar Trials